Back to search

Liposomal Vaccines: Clinical Status and Immunological Presentation for Humoral and Cellular Immunity

Data up to Jan 2025

Published1995
Citations68
References52

Total Citations Per Year

Abstract

References (52)

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1988 • 1,105 citations

Liposomes as drug carriers

1977 • 664 citations

Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome)

1988 • 404 citations

Liposomes as carriers of antigens and adjuvants

1991 • 350 citations

The Cell Biology of Antigen Processing and Presentation

1991 • 349 citations

A Vital Stain for the Golgi Apparatus

1985 • 344 citations

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

1992 • 231 citations

Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.

1991 • 164 citations

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.

1992 • 158 citations

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

1993 • 150 citations

Macrophages as accessory cells for class I MHC-restricted immune responses.

1991 • 148 citations

In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes.

1992 • 133 citations

Cellular Interactions in the Humoral Immune Response

1989 • 121 citations

Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses.

1992 • 117 citations

pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein

1991 • 114 citations

Lipid traffic in eukaryotic cells: mechanisms for intracelluar transport and organelle-specific enrichment of lipids

1990 • 114 citations

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens

1992 • 109 citations

Antiviral Cytotoxic T Lymphocyte Induction and Vaccination

1988 • 98 citations

Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway.

1992 • 90 citations

Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells

1993 • 86 citations

Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors.

1989 • 85 citations

Antigen presentation 1

1989 • 78 citations

Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages

1992 • 74 citations

Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.

1992 • 71 citations

The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen.

1989 • 69 citations

Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses

1990 • 63 citations

Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen

1991 • 63 citations

A rational design of synthetic peptide vaccine with a built‐in adjuvant

1992 • 63 citations

The role of macrophages in promoting the antibody response mediated by liposome-associated protein antigens

1982 • 62 citations

A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks

1992 • 59 citations

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

1992 • 53 citations

Liposome‐mediated delivery stimulates a class I‐restricted cytotoxic T cell response to soluble antigen

1992 • 53 citations

ATP-dependent fusion of liposomes with the Golgi apparatus of perforated cells

1988 • 50 citations

The Golgi apparatus: insights from lipid biochemistry

1990 • 48 citations

Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway

1993 • 46 citations

Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression.

1992 • 40 citations

Antigen presentation at the inflammatory site.

1989 • 40 citations

Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes

1993 • 40 citations

Intramuscular absorption and regional lymphatic uptake of liposome-entrapped inulin.

1981 • 37 citations

Liposomes in Immunology: The Immune Response Against Antigen-Containing Liposomes

1977 • 36 citations

Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382)

1992 • 34 citations

An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation

1991 • 33 citations

Novel Adjuvant Strategies for Experimental Malaria and AIDS Vaccines

1993 • 32 citations

Postimmunization Clearance of Liposome Entrapped Adenovirus Type 5 Hexon

1982 • 29 citations

In vitro fusion of rabbit liver Golgi membranes with liposomes.

1993 • 24 citations

Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes.

1984 • 23 citations

In vitro induction of primary and secondary xenoimmune responses by liposomes containing human colon tumor cell antigens

1982 • 22 citations

Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.

1986 • 18 citations

Design of a Complete Synthetic Peptide-Based AIDS Vaccine with a Built-in Adjuvant

1992 • 18 citations

H-2 antigens incorporated into phospholipid vesicles elicit specific allogeneic cytotoxic T lymphocytes

1980 • 18 citations

A study of the inability of subcellular fractions to elicit primary anti-H-2 cytotoxic T lymphocytes

1981 • 9 citations

Liposomes as Safe Carriers of Drugs and Vaccines

1992 • 3 citations

Cited By (0)

No citing papers found in database

Liposomal Vaccines: Clinical Status and Immunological Presentation for Humoral and… (1995) – Annals of the New York Academy of Sciences | Metascience Observatory Explorer